| 12168664 |
Triazolopyrimidines, their preparation and use |
Konstantin Petrukhin, Kirsten Alison Rinderspacher, Shi-Xian Deng, Andras Varadi, Boglarka Racz +3 more |
2024-12-17 |
$1,919,000 |
| 10815199 |
NMDA antagonist prodrugs |
Gunnar Nordvall, Katharina Högdin, Per Jonas Malmborg, Annika Kers, Dirk Reinhold Weigelt +2 more |
2020-10-27 |
$181,735,000 |
| 10207994 |
NMDA antagonist prodrugs |
Gunnar Nordvall, Katharina Högdin, Per Jonas Malmborg, Annika Kers, Dirk Reinhold Weigelt +2 more |
2019-02-19 |
$91,069,000 |
| 9822075 |
NMDA antagonist prodrugs |
Gunnar Nordvall, Katharina Högdin, Per Jonas Malmborg, Annika Kers, Dirk Reinhold Weigelt +2 more |
2017-11-21 |
$37,887,000 |
| 9035065 |
Ethanamine compounds and methods of using the same |
Michael Balestra, Glen Ernst, William Frietze, John McCauley, David Nugiel +1 more |
2015-05-19 |
$23,143,000 |
| 8389510 |
Crystalline forms |
Simon N. Black, Simon D. Broady, Alan S. Kirschner, James A. Osborn, Stewart D. Jolly +12 more |
2013-03-05 |
$3,955,000 |
| 8013165 |
Ethanamine compounds and methods of using the same 545 |
Michael Balestra, Glen Ernst, William Frietze, John McCauley, Lihong Shen +1 more |
2011-09-06 |
$3,679,000 |
| 7235541 |
Neurokinin antagonists for use as medicaments |
Jeffrey S. Albert, Cyrus J. Ohnmacht, Keith Russell, Ashokkumar B. Shenvi |
2007-06-26 |
$19,980,000 |
| 7045539 |
Therapeutic benzoxazole compounds |
Bernard Christophe Barlaam, Cathy Dantzman, Paul Warwick |
2006-05-16 |
$6,598,000 |
| 6963011 |
N-(2-phenyl-3-aminopropyl)naphthamides |
— |
2005-11-08 |
$17,398,000 |
| 6924277 |
Cyclized benzamide neurokinin antagonists for use in therapy |
— |
2005-08-02 |
$20,251,000 |
| 6903092 |
Naphthamide neurokinin antagonists for use as medicaments |
— |
2005-06-07 |
|
| 6846814 |
Neurokinin antagonists for use as medicaments |
Jeffrey S. Albert, Cyrus J. Ohnmacht, Keith Russell, Ashokkumar B. Shenvi |
2005-01-25 |
$7,985,000 |
| 6821973 |
Compounds |
— |
2004-11-23 |
$5,834,000 |
| 6586432 |
Neurokinin-1 receptor antagonists |
— |
2003-07-01 |
$37,972,000 |
| 6500818 |
Naphthalenecarboxamides as tachykinin receptor antagonists |
Robert Dedinas, Cyrus J. Ohnmacht, Keith Russell |
2002-12-31 |
$27,407,000 |
| 6476077 |
N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
— |
2002-11-05 |
$10,304,000 |
| 6365602 |
N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
Robert Dedinas, Keith Russell, Ashokkumar Shenyl |
2002-04-02 |
$7,047,000 |
| 6090824 |
Therapeutic neurokinin receptor antagonist compounds |
Bruce T. Dembofsky |
2000-07-18 |
$10,909,000 |
| 6054593 |
Proline derivatives |
Chris Allan Veale, Elwyn Peter Davies |
2000-04-25 |
$9,683,000 |
| 6048889 |
Proline derivatives |
Chris Allan Veale, Elwyn Peter Davies |
2000-04-11 |
$18,193,000 |
| 6008223 |
Therapeutic compounds |
Scott C. Miller |
1999-12-28 |
$5,310,000 |
| 5808097 |
Proline derivatives |
Chris Allan Veale, Elwyn Peter Davies |
1998-09-15 |
$1,890,000 |
| 5736535 |
1-pyrimidinylacetamide compounds which are inhibitors of human leukocyte elastase |
Philip D. Edwards, Andrew Shaw, Ashokkumar B. Shenvi, Royston M. Thomas, Chris Allan Veale +2 more |
1998-04-07 |
$4,403,000 |
| 5731309 |
Substituted heteroalkyleneamine neurokinin antagonists |
Scott C. Miller |
1998-03-24 |
$1,215,000 |
